Marc Zuckermann

Years Active: 2022-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Konstantin Okonechnikov, Piyush Joshi, Mari Sepp, Kevin Leiss, Ioannis Sarropoulos, Florent Murat, Martin Sill, Pengbo Beck, Kenneth Chun-Ho Chan, Andrey Korshunov, Felix Sahm, Maximilian Y Deng, Dominik Sturm, John DeSisto, Andrew M Donson, Nicholas K Foreman, Adam L Green, Giles Robinson, Brent A Orr, Qingsong Gao, Emily Darrow, Jennifer L Hadley, Paul A Northcott, Johannes Gojo, Daisuke Kawauchi, Volker Hovestadt, Mariella G Filbin, Andreas von Deimling, Marc Zuckermann, Kristian W Pajtler, Marcel Kool, David T W Jones, Natalie Jäger, Lena M Kutscher, Henrik Kaessmann, Stefan M Pfister
Mapping pediatric brain tumors to their origins in the developing cerebellum. Neuro-oncology (2023)
Romain Sigaud, Lisa Rösch, Charlotte Gatzweiler, Julia Benzel, Laura von Soosten, Heike Peterziel, Florian Selt, Sara Najafi, Simay Ayhan, Xenia F Gerloff, Nina Hofmann, Isabel Büdenbender, Lukas Schmitt, Kathrin I Foerster, Juergen Burhenne, Walter Emil Haefeli, Andrey Korshunov, Felix Sahm, Cornelis M van Tilburg, David T W Jones, Stefan M Pfister, Deborah Knoerzer, Brent L Kreider, Max Sauter, Kristian W Pajtler, Marc Zuckermann, Ina Oehme, Olaf Witt, Till Milde
The first-in-class ERK inhibitor ulixertinib shows promising activity in MAPK-driven pediatric low-grade glioma models. Neuro-oncology (2022)

Marc Zuckermann.css-eqlu8i{font-size:small;padding-left:4px;}